Skip to main content
Clinical Trials/ISRCTN56366401
ISRCTN56366401
Completed
N/A

Platelet Responsiveness and Outcome from Platelet Transfusion - does inherent variation in donor platelet function affect the clinical efficacy of apheresis platelets? A randomised double blind single centre trial.

HS Blood and Transplant [NHSBT] (UK)0 sites130 target enrollmentNovember 19, 2012

Overview

Phase
N/A
Intervention
Not specified
Conditions
ational Cancer Research Network, Blood
Sponsor
HS Blood and Transplant [NHSBT] (UK)
Enrollment
130
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 19, 2012
End Date
TBD
Last Updated
9 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
HS Blood and Transplant [NHSBT] (UK)

Eligibility Criteria

Inclusion Criteria

  • 1\. Age 16 years or older
  • 2\. Stable Haematology/Oncology Patients at Addenbrooke?s Hospital
  • 3\. Thrombocytopenia secondary to bone marrow failure, requiring platelet transfusions according to local and British Committee for Standards in Haematology (BCSH) Guidelines
  • 4\. Patients who, if peripheral venous access for blood sampling is required, have adequate access and will consent to their blood being taken in this way
  • 5\. Patients able to give written informed consent
  • 6\. Male or female

Exclusion Criteria

  • 1\. Inherited or acquired clotting disorders
  • 2\. Inherited or acquired platelet function disorders
  • 3\. Current Acute Promyelocytic Leukaemia
  • 4\. Previously documented WHO Grade 4 bleeding (debilitating blood loss)
  • 5\. Palpable Splenomegaly
  • 6\. Immunological refractoriness to platelet transfusion
  • 7\. Require HLA or HPA matched platelets
  • 8\. Pregnant or lactating women
  • 9\. Other active malignancy in past 5 years

Outcomes

Primary Outcomes

Not specified

Similar Trials